The Effectiveness of Chuna Maintenance Therapy for Chronic Bothersome Neck Pain

Launched by JASENG MEDICAL FOUNDATION · Sep 7, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how effective Chuna maintenance therapy is for people suffering from chronic neck pain that has lasted for 12 months or longer. Researchers are looking at two different groups: one group will receive Chuna therapy every two weeks for 20 weeks, while the other group will focus on lifestyle management and self-exercise, meeting once a month for the same duration. The study will include 250 participants aged 19 to 69 who have mild neck pain, but certain individuals with serious medical conditions or recent surgeries will not be eligible.

If you join this trial, you can expect to receive either the Chuna therapy or guidance on exercises and lifestyle changes over a period of 20 weeks. The goal is to see which approach helps reduce neck pain more effectively. This study is currently recruiting participants, so if you meet the criteria and are interested, you can consider signing up to contribute to this important research on managing neck pain.

Gender

ALL

Eligibility criteria

• * Inclusion Criteria:
• • 1. Aged 19 or older but under 70.
• • 2. Neck pain with pain duration of 12 months or longer
• • 3. NRS of neck pain over the past month is 2 or more but less than 4
• • 4. Patients who have agreed to trial participation and provided written informed consent
• * Exclusion Criteria:
• • 1. Patients diagnosed with serious pathology(s) which may cause neck pain (e.g. spinal metastasis of tumor(s), acute fracture, spinal dislocation)
• • 2. Patients with progressive neurologic deficit or severe neurologic symptoms such as spinal cord injury
• • 3. Patients whose pain is due to soft tissue disease not the spine (e.g. tumors, fibromyalgia, rheumatoid arthritis, gout)
• • 4. Patients with other chronic disease(s) which may interfere with treatment effect, safety, or interpretation of outcome (e.g. stroke and myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy)
• • 5. Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
• • 6. Pregnant patients or patients with plans of pregnancy or lactating patients
• • 7. Patients within 3 months after cervical surgery
• • 8. Patients with experience of participating in another clinical study within 1 month or plan to participate in another clinical study during the study participation and follow-up period within 6 months from the participation date
• • 9. Patients having difficult to completing the written informed consent
• • 10. Patients who are deemed unsuitable by the researchers